Dr. Kwatra’s Insights on Emerging Advances in Chronic Itch
chronic itchAs dermatologists, we recognize that chronic itch is a complex and often debilitating condition that significantly impacts our patients' quality of life, affecting their physical health, mental well-being, and daily activities. Chronic itch can be especially challenging to diagnose and treat, particularly in patients with skin of color, who may experience unique clinical manifestations and complic …
chronic itch
Case Series of Acral and Mucosal Melanoma in a Diverse Patient Population
acral melanomaINTRODUCTION Melanoma accounts for only 1% of all skin cancers but is responsible for most skin cancer-related deaths.1 Acral and mucosal melanoma (AMM) accounts for only 4% of all new melanomas but is associated with poorer prognosis.2 Patients of color are disproportionately affected by AMM. Elucidating the clinical, genetic, and environmental features of AMM can guide advancements in the …
acral melanoma
Addressing Skin Cancer Disparities: Unique Challenges and Solutions for Patients with Skin of Color
skin cancerDr. Valerie M. Harvey’s insightful presentation at the 2024 Skin of Color Update focused on the unique clinical and pathological features of basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma in patients with skin of color. As the founder and clinical director of the Hampton Roads Center for Dermatology and a past president of the Skin of Color Society, Dr. Harvey brought he …
skin cancer
Inverse Eruptive Syringoma in a Skin of Color Patient
SyringomaSyringomas are benign neoplasms derived from eccrine sweat glands. Eruptive syringomas are a subtype of syringomas and are typically located on the chest, neck, and abdomen during puberty or childhood. Herein, JDD authors Jennifer Wang BA, Nyousha Yousefi MD, Edward Heilman MD FAAD FCAP, and Jared Jagdeo MD MS present a 20-year-old African American female with an atypical case of eruptive syringom …
Syringoma
Sonidegib Therapeutic Cheat Sheet
SonidegibBasal cell carcinoma (BCC) is the most common human cancer. When curative surgery and radiotherapy are contraindicated, systemic agents targeting the hedgehog signaling pathway are invaluable options for this subset of adult patients with locally advanced BCC (laBCC). Vismodegib and sonidegib are oral options with similar efficacy and side effect profiles. With the absence of head-to-head comparis …
Sonidegib
error

Enjoy this blog? Please spread the word :)